What happened to your CFDs?

First 621 Last

Share
Profile

Follow
Shadowsfury

731 Posts.

17

07/05/24

11:24

Post #: 73701134
Share

Originally posted by thecrabpest: ↑

Ohhhhh haha, well that's awesome!

I'm not too worried about people taking shots at AKO, there are some very smart people on there, and some funny people, it has its value for sure. I would like a win here so I could get redemption there for laughs. We'll see...

I've shared my first investments on there, and shown other updates as I increased my holding. I'll maybe do another update if I get to my next target in shares.

I unfortunately lost my AKO CFDs (curse you NMT management) and now my holding is just in shares and options (no leverage).

I'm glad you can see the opportunity that I can see also, i had an idea that I'll share with Paul when I see him at the conference, about a dividend reinvestment plan.

I'd like the company to look into a slurry pipeline so we could expand beyond 2mtpa to 5 or 10 mtpa.

I think a slurry pipeline could cost up to $450m, and I'm thinking a good way to reward holders, and keep money in the company, would be to pay a big dividend, but also have a dividend reinvestment plan (DRP) in which holders could take shares instead of money, and get a 10% discount on those shares.

If I knew the DRP was a short term opportunity to fund and accelerate the build of a slurry pipeline, which would have a big impact on Opex costs, it would mean more tonnes shipped at a much lower cost, more profit and higher dividends with holders who reinvest owning a lot more shares, rather than buying them on market.

Anyways, I haven't even looked into it, it was just an idea that popped into my head...

Expand

What happened to your CFDs?

AKO Price at posting: 14.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

There are more pages in this discussion • 114 more messages in this thread...

First 621 Last

Add AKO (ASX) to my watchlist

(20min delay)
Last 10.0¢		Change 0.000(0.00%)		Mkt cap ! $12.04M

Open	High	Low	Value	Volume
10.0¢	11.0¢	10.0¢	$8.804K	86.14K

Buyers (Bids)

No.	Vol.	Price($)
3	116215	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	38863	1

View Market Depth

No.	Vol.	Price($)
3	116215	0.100
1	25000	0.095
1	97138	0.091
4	182841	0.090
1	11639	0.086

Price($)	Vol.	No.
0.110	38863	1
0.140	103108	2
0.150	79999	1
0.155	22284	1
0.175	3000	1

Last trade - 16.10pm 19/08/2024 (20 minute delay)

AKO (ASX) Chart

What happened to your CFDs?

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Fourfold skarn increase points the way to viable garnet project, says Pure

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

What happened to your CFDs?

Top Stories

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Fourfold skarn increase points the way to viable garnet project, says Pure

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News